Kelowna, BC / TheNewswire / August 14, 2017 - Marapharm Ventures Inc. "Marapharm" announces it has filed the 2017 year end annual audited financial statements and has granted stock options and other corporate items.

On March 6th, 2017, Marapharm granted a total of 1,000,000 stock options to company directors, consultants, and employees, with an exercise price of $1.49.  300,000 of these will expire on September 6th, 2017 and 700,000 will expire on June 3rd, 2018.  An additional 800,000 stock options were issued with an exercise price of $2.50.  These will expire on September 6th, 2017.

Marapharm also granted a total of 3,300,000 stock options on June 28, 2017 to company directors, consultants, and employees, with an exercise price of $1.02 which will expire on June 28th, 2019.

Marapharm has appointed a new auditor and has filed the March 31, 2017 annual audited financial statements and Management’s Discussion and Analysis on July 31, 2017.

Marapharm has issued 300,000 shares from treasury in payment of legal and consulting services incurred with a US firm over the past 18 months.